The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of androgen deprivation therapy and the androgen receptor ligand–directed degrader (BMS-986365) prior to radical prostatectomy in patients with high-risk localized prostate cancer.
 
Kristine Lacuna
Honoraria - Aptitude Health; Bayer; Curio Science; Dava Oncology; IDEOlogy Health; Topline Bio
Consulting or Advisory Role - Aptitude Health; Bayer; Curio Science; Dava Oncology; IDEOlogy Health; Topline Bio
Travel, Accommodations, Expenses - Bayer; Consens/Digital Science Press; Dava Oncology; IDEOlogy Health; IDEOlogy Health
 
Glenn Heller
No Relationships to Disclose
 
Brett Carver
No Relationships to Disclose
 
Anuradha Gopalan
No Relationships to Disclose
 
Wassim Abida
Honoraria - Aptitude Health; Clinical Education Alliance; Medscape; OncLive/MJH Life Sciences; Pfizer; Prostate Cancer Foundation; Roche; theMedNet; touchIME
Consulting or Advisory Role - AstraZeneca/MedImmune; Boundless Bio; Clovis Oncology; Daiichi Sankyo; DualityBio; Endeavor BioMedicines; IDEOlogy Health; Janssen; K36 Therapeutics; Laekna Therapeutics; MOMA Therapeutics; ORIC Pharmaceuticals; Pfizer; Tolmar
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Epizyme (Inst); Merus (Inst); MOMA Therapeutics (Inst); Nuvation Bio (Inst); ORIC Pharmaceuticals (Inst); TransThera Biosciences (Inst); Zenith Epigenetics (Inst)
(OPTIONAL) Uncompensated Relationships - Nuvation Bio
 
Karen Autio
Honoraria - MashupMedia
Consulting or Advisory Role - Fusion Pharmaceuticals; VIR Biotechnology
Research Funding - Amgen Astellas BioPharma (Inst); AstraZeneca (Inst); Janssen (Inst); Janux Therapeutics (Inst); Pfizer (Inst)
 
Yu Chen
Stock and Other Ownership Interests - ORIC Pharmaceuticals
Honoraria - Belharra Therapeutics; FOGPharma
Research Funding - Foghorn Therapeutics
Patents, Royalties, Other Intellectual Property - invention related to glucocorticoid inhibitors for treatment of prostate cancer (SK2013-045),; invention related to glucocorticoid inhibitors for treatment of prostate cancer (SK2013-045),
 
Matthew Dallos
Honoraria - Aptitude Health; Curio Science; IDEOlogy Health
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Johnson & Johnson/Janssen
Speakers' Bureau - dava oncology
Research Funding - Johnson & Johnson/Janssen (Inst)
Travel, Accommodations, Expenses - dava oncology
 
Daniel Danila
Honoraria - Amgen; Cambridge Healthtech Institute; Merck; Pfizer
Consulting or Advisory Role - Amgen; Angle; BioView; Pfizer; Sanador
Research Funding - Amgen (Inst); Janssen Research & Development (Inst); Pfizer (Inst); Prostate Cancer Foundation
Patents, Royalties, Other Intellectual Property - GENE EXPRESSION PROFILE ASSOCIATED WITH PROSTATE CANCER
Travel, Accommodations, Expenses - Amgen; Cambridge Healthtech Institute; EMD Serono; Prostate Cancer Foundation
 
Christopher Gaffney
No Relationships to Disclose
 
Anis Hamid
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer
Research Funding - Amgen; Convergent Therapeutics (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Thomas Kole
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - ImmunityBio; ImmunityBio (I); Johnson & Johnson; Johnson & Johnson (I); Madrigal Pharmaceuticals; Madrigal Pharmaceuticals (I); Viking Therapeutics; Viking Therapeutics (I)
Honoraria - Brainlab
Travel, Accommodations, Expenses - Brainlab
 
Deaglan McHugh
Honoraria - Korean Prostate Society
Consulting or Advisory Role - Johnson & Johnson/Janssen
Research Funding - AstraZeneca; Johnson & Johnson/Janssen
 
Michael Morris
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Advancelle; Amgen; ARTbio; Arvinas; Bristol-Myers Squibb; Convergent Therapeutics; Exelixis; Flare Therapeutics; Fusion Pharmaceuticals; Isotopia; Lantheus Medical Imaging; Mashup Media; Molecular Partners; Soffinova; Transtherabio; Wren Laboratories; Z-Alpha
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Abbvie; APCCC; Memorial Sloan-Kettering Cancer Center
(OPTIONAL) Uncompensated Relationships - Amgen; Bayer; Halda Therapeutics; Janssen Oncology; Novartis
 
Charles Ryan
Honoraria - Bayer; Janssen Oncology; Novartis; Pfizer
Consulting or Advisory Role - ORIC Pharmaceuticals; Tolmar; VIR Biotechnology
Other Relationship - ArsenalBio; Bayer; Lilly
 
Susan Slovin
Consulting or Advisory Role - Aptitude Health; Bayer; Curio Science; Foundation Medicine; ITA Partners; MJH Life Sciences; Pfizer; PSI Pharma Support America
Research Funding - AstraZeneca
 
Karyna Atha
No Relationships to Disclose
 
Nicole Smith
No Relationships to Disclose
 
Dana Rathkopf
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Celgene; Genentech; Janssen; Myovant Sciences; Novartis; Promontory
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Novartis (Inst); Promontory Therapeutics (Inst)